Morning Edition · №
Trending · Fitness LONDON

Forget 10,000 Steps: Study Says Walking Pace Matters More for Longevity

A study tracking roughly 64,000 UK adults found that walking faster, even for fewer total steps, was linked to meaningfully lower mortality risk, challenging a decades-old fitness target with roots in 1960s marketing.

SHARE X f in ⧉

A widely discussed study tracking roughly 64,000 adults in the United Kingdom has found that walking pace, not total step count, may be the more important factor in predicting longevity. Researchers led by Charles Stamatakis found that a brisker cadence of around 90 to 100 steps per minute was associated with meaningfully lower mortality risk, even among participants who logged fewer total steps than their slower-walking peers.

The findings directly challenge the familiar "10,000 steps a day" benchmark, a target researchers trace not to clinical science but to a 1960s Japanese pedometer marketing campaign rather than any peer-reviewed study. An exercise physiologist at the University at Buffalo, discussing the research in follow-up coverage, explained the likely mechanism: walking faster places greater demand on the heart, lungs and muscles than a slow stroll, improving cardiovascular fitness and metabolic health over time in a way that simply accumulating steps at a leisurely pace does not.

The study has continued generating discussion in health media in the weeks since it was first reported, in part because its practical message is simple and actionable: a brisk 10-to-15-minute walk may do more for long-term health than a slower walk that technically racks up more total steps. For readers trying to decide how to spend limited exercise time, the research offers a reason to prioritize intensity over sheer distance — a shift the original coverage of the findings frames as a meaningful departure from decades of step-counting orthodoxy.

SHARE THIS ARTICLE X Facebook LinkedIn Copy link
Samuel Okafor · Health & Medicine Correspondent

Covers health and medicine for UBStandard: drug approvals, clinical research and the systems that deliver care.

[email protected]
Related coverage Front page →